Texas Yale Capital Corp. Gossamer Bio, Inc. Transaction History
Texas Yale Capital Corp.
- $2.47 Billion
- Q4 2024
A detailed history of Texas Yale Capital Corp. transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Texas Yale Capital Corp. holds 10,000 shares of GOSS stock, worth $13,899. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$13,899% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding GOSS
# of Institutions
116Shares Held
163MCall Options Held
821KPut Options Held
557K-
Octagon Capital Advisors LP New York, NY18.4MShares$25.5 Million3.68% of portfolio
-
Nea Management Company, LLC Timonium, MD18.1MShares$25.1 Million1.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$13.9 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL8.81MShares$12.2 Million0.03% of portfolio
-
Arch Venture Management, LLC Chicago, IL8.06MShares$11.2 Million4.56% of portfolio
About Gossamer Bio, Inc.
- Ticker GOSS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 93,954,000
- Market Cap $131M
- Description
- Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...